deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03227198

IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients (IMMNC-HF)

Evaluation of the Intramyocardial Injection of Autologous Bone Marrow Derived Mononuclear Stem Cells in Heart Failure (HF) Patients

Sponsor: SCARM Institute, Tabriz, Iran

Conditions Heart Failure
Interventions Intramyocardial injection of stem cell Placebo
Updated 14 times since 2017 Last updated: Oct 24, 2020 Started: Oct 14, 2020 Primary completion: Aug 10, 2021 Completion: Oct 12, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03227198, this PHASE1/PHASE2 trial focuses on Heart Failure and remains ongoing. Sponsored by SCARM Institute, Tabriz, Iran, it has been updated 14 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshot~Mar 2019 – ~Dec 2019 · 9 months · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Not Yet Recruiting → Unknown Status

  5. Jan 2021 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

▶ Show 9 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  2. Apr 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  3. Dec 2019 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  4. Mar 2019 — Dec 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  5. Sep 2018 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  6. Aug 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  7. Jun 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  8. Oct 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  9. Aug 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • SCARM Institute, Tabriz, Iran
Data source: SCARM Institute, Tabriz, Iran

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations